- Home/
- News & Events/
- Articles/
- In the News
Vaccine News: 2026 measles cases almost matching last year's total
July 17, 2026
Confirmed 2026 measles cases nearing 2025's total; Reserve your 2026-27 Influenza, COVID-19, and RSV vaccines today
FFF Enterprises is your single source for all respiratory (Influenza, COVID-19, RSV), pediatric, adult, and travel vaccine needs. Download our complimentary Respiratory Vaccines Reference Chart and Complete Vaccine Products Reference Guide.
Influenza Vaccines - 2026-27 Trivalent Influenza Vaccines
Reserve your 2026-27 Influenza vaccines on BioSupply® now. Help bend the curve of flu-related hospitalizations and deaths this upcoming flu season by planning ahead.
The importance of influenza vaccination was underscored this past June when the Pentagon announced military recruits in boot camps for all military services will be required once again to receive flu shots. The decision followed a flu outbreak affecting nearly 300 people at Lackland Air Fore Base.
*As a reminder, CSL Seqirus sunsetted AFLURIA® for the 2026-27 respiratory season in order to deliver "a fully differentiated portfolio that supports improved clinical outcomes for all eligible individuals aged 6 months and older." See available flu vaccines via the link below.
COVID-19 Vaccines - 2026-27 Season Offerings
The CDC stated on July 10 that COVID-19 activity in the U.S. is low and stable, but it is beginning to increase in a few areas of the country. View our COVID-19 product page for a complete list.
Reminder: FFF now carries the first monoclonal antibody specifically for immunocompromised patients with Invivyd's PEMGARDA® (pemivibart) Injection IgG1λ Monoclonal Antibody (mAb). Prescribing information for PEMGARDA available here.
Respiratory Syncytial Virus (RSV)
On July 10, the CDC stated RSV activity is very low in most areas of the U.S. RSV-related emergency department visits and hospitalizations are low but remain highest for children younger than 4 years old.
Immunizations are recommended by the CDC for infants, some young children, and adults who are older or have certain risk factors that increase severe RSV illness potential. View FFF's RSV vaccine product page.
Travel Vaccines - Vaccine Access
FFF can help your patients who are traveling this summer stay safe with our comprehensive travel vaccine portfolio. The CDC posted no additional Travel Health Notices (THN) since June 15. Visit their website for any new announcements.
Adult Vaccines - Protecting Patients Against Severe Illness
Take a look at our adult vaccine product page to review our extensive adult vaccines that are in stock and ready to ship today. Visit the CDC for adult immunization schedules. Let FFF help keep your adult patients and their communities healthy.
Pediatric Vaccines - For Youth Immunization
Communities across the U.S. are continuing to battle measles cases. As of July 9, the CDC received 2,234 confirmed measles cases this year, reported by 42 jurisdictions. By comparison, there were a total of 2,289 confirmed U.S. cases in 45 jurisdictions in all of 2025.
Ages 5 to 19 comprise 50 percent of the cases while 20 percent belong to children age 5 and younger. The CDC states that the measles, mumps, and rubella (MMR) vaccine is "very safe and effective." They note that when 95 percent of a community is vaccinated, most people are protected through herd immunity. However, vaccination rates have dropped in recent years. Help your community get vaccinated today with our help! Visit FFF's pediatric vaccines product page for other available pediatric immunizations.
